Brief: Klaria Submits Cannabinoid Formulation Patent Application
March 7 (Reuters) - Klaria Pharma Holding AB (publ)
KLAR.ST :
* KLARIA SUBMITS CANNABINOID FORMULATION PATENT APPLICATION
FOLLOWING SIGNIFICANT PROGRESS
* KLARIA ANNOUNCES COMPLETION AND FILING OF A PATENT
APPLICATION
FOR A UNIQUE CANNABINOID FORMULATION
Source text for Eikon: ID:nWkr7V8BWS
Further company coverage: KLAR.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Klaria Pharma Holding AB (publ)
See all newsBrief: Klaria Gets Additional Subscription Commitments, Extends Subscription Period
Brief: Klaria Pharma Publishes Summary Of External Valuation
Brief: Klaria Pharma To Decide On Rights Issue Of Up To SEK 147.6 Mln
Brief: Klaria Pharma To Carry Out Rights Offering
Brief: Klaria, RTHS Enter Collaboration Agreement